JEMPERLI 500 mg concentrate for solution for infusion, Zejula 100 mg film-coated tablets
2020/3093 NIRADO
Phase 2 small_molecule active
Quick answer
JEMPERLI 500 mg concentrate for solution for infusion, Zejula 100 mg film-coated tablets for DNA repair-deficient or platinum-sensitive solid tumors is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- DNA repair-deficient or platinum-sensitive solid tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active